Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial phospholipid bilayer is a fundamental structural and functional barrier in bacteria and fungi, essential for maintaining cellular integrity and regulating the transport of ions and nutrients (Epand et al., 2016). Unlike the zwitterionic membranes of mammalian cells, bacterial membranes are typically rich in anionic phospholipids such as phosphatidylglycerol and cardiolipin, which provide a selective target for cationic antimicrobial agents (Malanovic & Lohner, 2016). In fungi, the presence of ergosterol instead of cholesterol further differentiates the microbial membrane from host cells, allowing for targeted disruption by polyene antifungals (NIH, 2023). Therapeutic agents like daptomycin and polymyxins exploit these differences to bind, insert into, and disrupt the membrane, causing rapid depolarization or physical pore formation that leads to cell death (StatPearls, 2023). This target is highly significant in the treatment of multi-drug resistant (MDR) infections because the membrane's physical integrity is essential for viability and is less prone to simple mutational resistance than specific metabolic enzymes. However, the clinical utility of membrane-targeting drugs is often constrained by their narrow therapeutic window and the risk of systemic toxicities, most notably nephrotoxicity and neurotoxicity, due to partial cross-reactivity with host cell membranes (Nation et al., 2014).
Direct binding to microbial-specific lipids (e.g., phosphatidylglycerol or ergosterol) followed by membrane insertion and oligomerization, leading to pore formation, depolarization of the transmembrane potential, and leakage of essential intracellular contents (Malanovic & Lohner, 2016; StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial phospholipid bilayer.